Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Navidea Biopharmaceuticals, Inc. NAVB

Full chart Compare
Set alert

Price alert · NAVB

All alert types
0.00 0.00 (+0.00%)

Jan 8, 2026, 9:30 AM EST

0.0001 Day range 0.0001

52-week range unavailable

Financial health

Altman Z-Score

-100.75 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2013: -5.9×FY 2014: -7.9×FY 2015: -7.3×FY 2016: -6.9×FY 2017: 0.8×FY 2018: -1.1×FY 2019: -1.7×FY 2020: -4.5×FY 2021: -2.5×FY 2022: -0.4×
FY 2013 5y median -1.7× FY 2022
P/S 93.9×
FY 2013: 223×FY 2014: 44.8×FY 2015: 15.2×FY 2016: 4.5×FY 2017: 32.0×FY 2018: 54.3×FY 2019: 681×FY 2020: 56.1×FY 2021: 55.2×FY 2022: 93.9×
FY 2013 5y median 56.1× FY 2022
P/B -0.7×
FY 2013: -62.9×FY 2014: -9.4×FY 2015: -3.7×FY 2016: -1.5×FY 2017: 5.1×FY 2018: 10.1×FY 2019: -11.2×FY 2020: 39.1×FY 2021: -275×FY 2022: -0.7×
FY 2013 5y median -0.7× FY 2022
P/FCF -0.7×
FY 2013: -6.8×FY 2014: -9.3×FY 2015: -10.5×FY 2016: 27.9×FY 2017: 1.0×FY 2018: 4.1×FY 2019: -1.9×FY 2020: -6.0×FY 2021: -2.8×FY 2022: -0.7×
FY 2013 5y median -1.9× FY 2022
EV/EBITDA -0.5×
FY 2013: -6.5×FY 2014: -9.8×FY 2015: -12.0×FY 2016: -23.2×FY 2017: -4.2×FY 2018: -1.3×FY 2019: -1.7×FY 2020: -4.7×FY 2021: -2.2×FY 2022: -0.5×
FY 2013 5y median -1.7× FY 2022
EV/Sales 101×
FY 2013: 218×FY 2014: 49.3×FY 2015: 19.2×FY 2016: 7.2×FY 2017: 30.8×FY 2018: 44.5×FY 2019: 682×FY 2020: 54.7×FY 2021: 48.7×FY 2022: 101×
FY 2013 5y median 54.7× FY 2022
FCF Yield -152.2%
FY 2013: -14.6%FY 2014: -10.8%FY 2015: -9.5%FY 2016: 3.6%FY 2017: 101.9%FY 2018: 24.2%FY 2019: -51.9%FY 2020: -16.7%FY 2021: -35.9%FY 2022: -152.2%
FY 2013 5y median -35.9% FY 2022

Profitability

Gross Margin -259.4%
FY 2013: 70.6%FY 2014: 74.7%FY 2015: 86.8%FY 2016: 89.5%FY 2017: 99.8%FY 2018: 70.0%FY 2019: 75.0%FY 2020: 99.9%FY 2021: 62.6%FY 2022: -259.4%
FY 2013 5y median 70.0% FY 2022
Operating Margin -21402.1%
FY 2013: -3399.7%FY 2014: -440.4%FY 2015: -140.0%FY 2016: -10.1%FY 2017: -766.5%FY 2018: -3363.3%FY 2019: -41184.6%FY 2020: -1170.6%FY 2021: -2269.1%FY 2022: -21402.1%
FY 2013 5y median -3363.3% FY 2022
Net Margin -23117.6%
FY 2013: -3776.6%FY 2014: -569.4%FY 2015: -208.0%FY 2016: -65.1%FY 2017: 4139.7%FY 2018: -5000.1%FY 2019: -41120.9%FY 2020: -1171.8%FY 2021: -2207.1%FY 2022: -23117.6%
FY 2013 5y median -5000.1% FY 2022
ROE 179.9%
FY 2013: 1064.9%FY 2014: 119.9%FY 2015: 50.8%FY 2016: 21.0%FY 2017: 658.6%FY 2018: -932.4%FY 2019: 678.9%FY 2020: -815.0%FY 2021: 11009.2%FY 2022: 179.9%
FY 2013 5y median 179.9% FY 2022
ROIC 280.6%
FY 2013: -116.1%FY 2014: -385.2%FY 2015: -200.5%FY 2016: 39.0%FY 2017: -71.1%FY 2018: -274.9%FY 2019: -963.0%FY 2020: -262.3%FY 2021: -581.5%FY 2022: 280.6%
FY 2013 5y median -274.9% FY 2022
ROA -347.2%
FY 2013: -105.9%FY 2014: -299.7%FY 2015: -184.2%FY 2016: -114.8%FY 2017: 360.6%FY 2018: -230.1%FY 2019: -263.7%FY 2020: -138.2%FY 2021: -176.5%FY 2022: -347.2%
FY 2013 5y median -230.1% FY 2022

Growth (YoY)

Revenue -87.6%
FY 2013: 1335.9%FY 2014: 455.0%FY 2015: 111.1%FY 2016: 65.8%FY 2017: -91.8%FY 2018: -82.2%FY 2019: -91.7%FY 2020: 3337.6%FY 2021: -41.9%FY 2022: -87.6%
FY 2013 FY 2022
Operating Income -16.5%
FY 2013: -37.3%FY 2014: 28.1%FY 2015: 32.9%FY 2016: 88.0%FY 2017: -524.1%FY 2018: 21.8%FY 2019: -1.1%FY 2020: 2.3%FY 2021: -12.6%FY 2022: -16.5%
FY 2013 FY 2022
EPS (diluted) -40.0%
FY 2013: -19.0%FY 2014: 31.5%FY 2015: 24.0%FY 2016: 49.6%FY 2017: 589.1%FY 2018: -121.0%FY 2019: 59.8%FY 2020: 36.8%FY 2021: 16.7%FY 2022: -40.0%
FY 2013 FY 2022
Free Cash Flow 11.1%
FY 2013: -50.0%FY 2014: 17.8%FY 2015: 36.9%FY 2016: 118.6%FY 2017: 1561.1%FY 2018: -92.8%FY 2019: -322.5%FY 2020: 8.8%FY 2021: -22.8%FY 2022: 11.1%
FY 2013 FY 2022

Financial Health

Current Ratio 0.3×
FY 2013: 3.3×FY 2014: 0.9×FY 2015: 2.0×FY 2016: 0.2×FY 2017: 1.7×FY 2018: 1.5×FY 2019: 0.8×FY 2020: 1.4×FY 2021: 1.0×FY 2022: 0.3×
FY 2013 5y median 1.0× FY 2022
Quick Ratio 0.3×
FY 2013: 3.1×FY 2014: 0.8×FY 2015: 1.9×FY 2016: 0.1×FY 2017: 1.7×FY 2018: 1.5×FY 2019: 1.0×FY 2020: 1.3×FY 2021: 1.0×FY 2022: 0.3×
FY 2013 5y median 1.0× FY 2022
Debt / Equity -0.3×
FY 2013: -6.9×FY 2014: -1.1×FY 2015: -1.1×FY 2016: -0.9×FY 2017: 0.2×FY 2018: 0.2×FY 2019: -0.7×FY 2020: 1.0×FY 2021: -7.0×FY 2022: -0.3×
FY 2013 5y median -0.3× FY 2022
Net Debt / EBITDA -0.0×
FY 2013: 0.1×FY 2014: -0.9×FY 2015: -2.5×FY 2016: -8.7×FY 2017: 0.2×FY 2018: 0.3×FY 2019: -0.0×FY 2020: 0.1×FY 2021: 0.3×FY 2022: -0.0×
FY 2013 5y median 0.1× FY 2022
Interest Coverage -12.8×
FY 2013: -13.8×FY 2014: -7.5×FY 2015: -14.6×FY 2016: -457×FY 2017: -82.1×FY 2018: -352×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -1896×FY 2022: -12.8×
FY 2013 5y median -12.8× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31